Volume 70; Issue 2

Main
The Prostate
Volume 70; Issue 2

The Prostate

Volume 70; Issue 2

1

PSA and body composition by dual X-Ray absorptiometry (DXA) in NHANES

Jay H. Fowke, Charles E. Matthews

Journal:

Year:

2010

Language:

english

File:

PDF, 81 KB

english, 2010

2

p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2

Carolin C. Schneider, Andrea Hessenauer, Mathias Montenarh, Claudia Götz

Journal:

Year:

2010

Language:

english

File:

PDF, 200 KB

english, 2010

3

PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators

P.W. van Duijn, A.C.J. Ziel-van der Made, J.A.G. van der Korput, J. Trapman

Journal:

Year:

2010

Language:

english

File:

PDF, 389 KB

english, 2010

4

Prolongation of off-cycle interval by finasteride is not associated with survival improvement in intermittent androgen deprivation therapy in LNCaP tumor model

Yujuan Wang, Shubham Gupta, Vi Hua, Raquel Ramos-Garcia, Daniel Shevrin, Borko D. Jovanovic, Joel B. Nelson, Zhou Wang

Journal:

Year:

2010

Language:

english

File:

PDF, 133 KB

english, 2010

5

Bone metabolic disorder in patients with prostate cancer receiving androgen deprivation therapy (ADT): impact of ADT on the growth hormone/insulin-like growth factor-1/parathyroid hormone axis

Etsuko Isahaya, Noboru Hara, Tsutomu Nishiyama, Tatsuhiko Hoshii, Itsuhiro Takizawa, Kota Takahashi

Journal:

Year:

2010

Language:

english

File:

PDF, 97 KB

english, 2010

6

No association between variant DNA repair genes and prostate cancer risk among men of African descent

Nicole A. Lavender, Oyeyemi O. Komolafe, Marnita Benford, Guy Brock, Jason H. Moore, Tiva T. VanCleave, J. Christopher States, Rick A. Kittles, La Creis R. Kidd

Journal:

Year:

2010

Language:

english

File:

PDF, 98 KB

english, 2010

7

Ets-1 and hypoxia inducible factor-1α inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer

Takeo Kosaka, Akira Miyajima, Suguru Shirotake, Eiji Kikuchi, Masanori Hasegawa, Shuji Mikami, Mototsugu Oya

Journal:

Year:

2010

Language:

english

File:

PDF, 238 KB

english, 2010

8

SRD5A2 V89L polymorphism and prostate cancer risk: A meta-analysis

Chunyang Wang, Weiyang Tao, Qiyin Chen, Hailong Hu, Xiao-Yan Wen, Ruifa Han

Journal:

Year:

2010

Language:

english

File:

PDF, 113 KB

english, 2010

9

Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Purα-mediated decrease in androgen receptor levels

XiaoMei Liu, Alejandro Gomez-Pinillos, XiaoJun Liu, Edward M. Johnson, Anna C. Ferrari

Journal:

Year:

2010

Language:

english

File:

PDF, 427 KB

english, 2010

10

Tumor suppressor PAX6 functions as androgen receptor Co-repressor to inhibit prostate cancer growth

Chih-Rong Shyr, Meng-Yin Tsai, Shuyuan Yeh, Hong-Yo Kang, Yun-Chao Chang, Pei-Ling Wong, Chao-Cheng Huang, Ko-En Huang, Chawnshang Chang

Journal:

Year:

2010

Language:

english

File:

PDF, 346 KB

english, 2010

11

Radical prostatectomy: Influence on serum and urinary androgen levels

Mats Olsson, Lena Ekström, Jenny Schulze, Anders Kjellman, Olof Akre, Anders Rane, Ove Gustafsson

Journal:

Year:

2010

Language:

english

File:

PDF, 83 KB

english, 2010

12

Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer

Junya Furukawa, Christopher J. Wraight, Susan M. Freier, Eigan Peralta, Lynne M. Atley, Brett P. Monia, Martin E. Gleave, Michael E. Cox

Journal:

Year:

2010

Language:

english

File:

PDF, 470 KB

english, 2010

13

Docetaxel–ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression

Francesco Fabbri, Giovanni Brigliadori, Silvia Carloni, Paola Ulivi, Anna Tesei, Rosella Silvestrini, Dino Amadori, Wainer Zoli

Journal:

Year:

2010

Language:

english

File:

PDF, 154 KB

english, 2010